Diabetes Metab J.  2020 Dec;44(6):933-937. 10.4093/dmj.2020.0156.

Trends in the Incidence, Prevalence, and Mortality of End-Stage Kidney Disease in South Korea

Affiliations
  • 1Department of Nephrology, Ajou University School of Medicine, Suwon, Korea
  • 2Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea
  • 3Department of Cardiovascular and Metabolic Disease Etiology Research Center, Ajou University School of Medicine, Suwon, Korea

Abstract

Knowledge of the epidemiologic characteristics of end-stage kidney disease (ESKD) patients is essential. The trends in the prevalence, incidence, and mortality rates of ESKD were analyzed retrospectively using the Korean National Health Insurance ServiceNational Sample Cohort database between 2006 and 2015. From 2006 to 2015, the incidence of ESKD decreased from 28.6 to 24.0 per 100,000 people and showed a decreasing pattern with or without diabetes mellitus. However, the incidence of those aged ≥75 years increased, as did the mean age at the onset of ESKD. From 2007 to 2015, the prevalence of ESKD increased in all age groups, but particularly in those aged ≥75 years. The prevalence of ESKD differed by sex and diabetes mellitus status and this gap widened over time. Mortality rates in ESKD patients remained relatively constant throughout the study period. However, mortality rates in ESKD without diabetes decreased over the same period.

Keyword

Diabetes mellitus; Incidence; Kidney failure; chronic; Mortality; Prevalence

Figure

  • Fig. 1 Incidence, prevalence, mortality rates of end-stage kidney disease in South Korea, 2006 to 2015 by age group, sex, and diabetes mellitus status. (A) Incidence rate by age group. (B) Incidence rate by sex. (C) Incidence rate by diabetes mellitus status. (D) Prevalence rate by age group. (E) Prevalence rate by sex. (F) Prevalence rate by diabetes mellitus status. (G) Mortality rate by age group. (H) Mortality rate by sex. (I) Mortality rate by diabetes mellitus status. (A, D, G) ‘All ages’ are shown as standardized values, and the remaining subdivided age groups are shown as crude values.

  • Fig. 2 The most common causes of death as proportions of all deaths in end-stage kidney disease patients (A), in end-stage kidney disease patients with diabetes mellitus (B), and in end-stage kidney disease patients without diabetes mellitus (C) during 2007 to 2015.


Cited by  2 articles

Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
Nam Hoon Kim, Nan Hee Kim
Diabetes Metab J. 2022;46(4):543-551.    doi: 10.4093/dmj.2022.0209.

Association between N-Terminal Prohormone Brain Natriuretic Peptide and Decreased Skeletal Muscle Mass in a Healthy Adult Population: A Cross-Sectional Study
Tae Kyung Yoo, Marie Yung-Chen Wu, Moon Soo Kim, Mi-Yeon Lee, Yong-Taek Lee, Kyung Jae Yoon, Chul-Hyun Park
Endocrinol Metab. 2023;38(2):269-276.    doi: 10.3803/EnM.2022.1588.


Reference

1. United States Renal Data System: 2018 USRDS annual data report. Chapter 11: International Comparisons. https://www.usrds.org/media/1738/v2_c11_intcomp_18_usrds.pdf (cited 2020 Oct 16).
2. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011; 305:2532–9.
Article
3. Van Dijk PC, Jager KJ, Stengel B, Gronhagen-Riska C, Feest TG, Briggs JD. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991–2000). Kidney Int. 2005; 67:1489–99.
Article
4. Jin DC. Dialysis registries in the world: Korean Dialysis Registry. Kidney Int Suppl (2011). 2015; 5:8–11.
Article
5. Jin DC. Analysis of mortality risk from Korean hemodialysis registry data 2017. Kidney Res Clin Pract. 2019; 38:169–75.
Article
6. Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2017; 46:e15.
Article
7. Weinstein JR, Anderson S. The aging kidney: physiological changes. Adv Chronic Kidney Dis. 2010; 17:302–7.
Article
8. O’Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, Walter LC, Mehta KM, Steinman MA, Allon M, McClellan WM, Landefeld CS. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007; 18:2758–65.
9. Won JC, Lee JH, Kim JH, Kang ES, Won KC, Kim DJ, Lee MK. Diabetes fact sheet in Korea, 2016: an appraisal of current status. Diabetes Metab J. 2018; 42:415–24.
Article
10. Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, de Boer IH. Clinical manifestations of kidney disease among US adults with diabetes, 1988–2014. JAMA. 2016; 316:602–10.
Article
11. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, Williams DE, Geiss L. Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med. 2014; 370:1514–23.
Article
Full Text Links
  • DMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr